Cancer

Lawson research team working to personalize cancer care

The Lawson Translational Cancer Research Team (LTCRT) of the Lawson Health Research Institute is one of five groups participating in a new study that seeks to personalize cancer drug treatment.

Cancer

Gene responsible for relapses in young leukemia patients

One of the causes of resistance to cancer treatment in children is now beginning to be elucidated. Acute lymphoblastic leukemia patients with a particular form of the ATF5 gene are at higher risk of having a relapse when ...

Genetics

Metabolomics as a basis for gender-specific drugs

Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at ...

Genetics

King Tut and half of European men share DNA

According to a group of geneticists in Switzerland from iGENEA, the DNA genealogy center, as many as half of all European men and 70 percent of British men share the same DNA as the Egyptian Pharaoh Tutankhamun, or King Tut.

Genetics

Novel analysis method organizes genomic cancer data

The technology that allows scientists to profile the entire genome of individual tumors offers new hope for discovering ways to select the best treatment for each patient's particular type of cancer. However, these profiles ...

page 6 from 8